Recurrent squamous cell carcinoma of the breast with undifferentiated features: Report of a case

Surgery Today

Volumn 32, Issue 10, 2002, Pages 891-895

  Miura, Hiroyuki ^a   Taira, Osamu ^a   Hiraguri, Shunsuke ^a   Maeda, Junichi ^a   Kato, Harubumi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast; Poor prognosis; Recurrent tumor; Squamous cell carcinoma; Undifferentiated feature

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; UNDIFFERENTIATED CARCINOMA;

BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 0036411828     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950200174     Document Type: Article

References (12)

1. Hasleton PS, Misch KA, Vasudev KS, George D. Squamous carcinoma of the breast. J Clin Pathol 1978;31:116-24.
2. Eggers JW, Chesney TM. Squamous carcinoma of the breast: A clinicopathologic analysis of eight cases and review of the literature. Hum Pathol 1984;15:526-31.
3. Woodard BH, Brinkhous AD, McCarty KS, McCarty KS Jr. Adenosquamous differentiation in mammary carcinoma. Arch Pathol Lab Med 1980;104:130-3.
4. Cornog JL, Mobini J, Steiger E, Enterline HT. Squamous cell carcinoma of the breast. Am J Clin Pathol 1971;55:410-7.
5. Rostock RA, Bauer TW, Eggleston JC. Primary squamous carcinoma of the breast: A review. Dis Breast 1984;10:27-31.
6. Wargotz ES, Norris HJ. Metaplastic carcinoma of the breast: IV. Squamous cell carcinoma of ductal origin. Cancer 1990;65:272-6.
7. Dorst EBL, Muijen GNP, Litvinov SV, Fleuren GJ. The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells. J Clin Pathol 1998; 51:679-84.
8. Gallager HS. Pathologic types of breast cancer: Their prognosis. Cancer 1984;53:623-9.
9. Toikkanen S. Primary squamous cell carcinoma of the breast. Cancer 1981;48:1629-32.
10. Paterson J, Furr B, Wakeling A, Battersby L. The biology and physiology of "Nolvadex" (tamoxifen) in the treatment of breast cancer. Breast Cancer Res Treat 1982;2:363-74.
11. Blackwell KL, Haroon ZA, Shan S, Saito W, Broadwater G, Greenberg CS, et al. Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res 2000;6:4359-64.
12. Dejager D, Redlich PN, Dayer AM, Davis HL, Komorowski RA. Primary squamous cell carcinoma of the breast: Sensitivity to cisplatinum-based chemotherapy. J Surg Oncol 1995;59:199-203.